ADMA BIOLOGICS INC (ADMA)

US0008991046 - Common Stock

6.55  +0.11 (+1.71%)

After market: 6.62 +0.07 (+1.07%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
80.9M
91.71%		154.1M
90.48%		258.215M
67.56%		340.55M
31.89%
EBITDA
YoY % growth
-52.9M
13.22%		-32.19M
39.15%		29.964M
193.08%		105.32M
251.49%
EBIT
YoY % growth
-58.4M
10.02%		-39.3M
32.71%		21.632M
155.04%		83.767M
287.24%
Operating Margin
-72.19%-25.50%8.38%24.60%
EPS
YoY % growth
-0.52
39.53%		-0.31
40.38%		-0.13
58.06%		0.30
333.42%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		0.06
287.00%
Revenue
Q2Q % growth		78.821M
38.50%
EBITDA
Q2Q % growth		19.482M
EBIT
Q2Q % growth		16.705M
2,162.35%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -0.08
-33.33%		0.03-0.11-413.73%
Q3 2023
Q2Q % growth		 0.01
112.50%		-0.010.02230.72%
Q2 2023
Q2Q % growth		 -0.03
57.14%		-0.030.00-17.65%
Q1 2023
Q2Q % growth		 -0.03
70.00%		-0.040.0130.80%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 73.904M
47.87%		73.593M310.68K0.42%
Q3 2023
Q2Q % growth		 67.27M
63.71%		63.368M3.902M6.16%
Q2 2023
Q2Q % growth		 60.12M
77.29%		56.61M3.51M6.20%
Q1 2023
Q2Q % growth		 56.91M
95.57%		54.477M2.433M4.47%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 69.23% 0% 83.08%
Revenue0% 7.66% 0% 13.96%